We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (median age 34 years) in Germany. These data emphasize that nonpharmaceutical interventions for coronavirus disease remain crucial and that additional immunizations for the elderly might become necessary.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Vaccine, Immunity, antibody, B cell, T cell, Germany, mRNA, Berlin, 【초록키워드】 coronavirus disease, coronavirus, vaccination, T-cell Response, Nonpharmaceutical interventions, immunization, healthcare worker, BNT162b2, Germany, T-cell responses, nonpharmaceutical intervention, These data, median age, reduced, 【제목키워드】 elderly, response, Delayed,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, Vaccine, Immunity, antibody, B cell, T cell, Germany, mRNA, Berlin, 【초록키워드】 coronavirus disease, coronavirus, vaccination, T-cell Response, Nonpharmaceutical interventions, immunization, healthcare worker, BNT162b2, Germany, T-cell responses, nonpharmaceutical intervention, These data, median age, reduced, 【제목키워드】 elderly, response, Delayed,
우리는 독일의 123명의 의료 종사자(중간 연령 34세)와 비교하여 71명의 노인(중앙 연령 81세)에서 BNT162b2 백신 접종 후 지연되고 감소된 항체 및 T 세포 반응을 발견했습니다. 이러한 데이터는 코로나바이러스 질병에 대한 비약물적 개입이 여전히 중요하며 노인을 위한 추가 예방접종이 필요할 수 있음을 강조합니다.